首页|间充质干细胞及其外泌体在药物性肝损伤治疗中的作用

间充质干细胞及其外泌体在药物性肝损伤治疗中的作用

扫码查看
药物性肝损伤(DILI)的发生率呈逐年上升趋势且损伤机制并不明确,针对DILI的治疗药物、肝脏支持系统及肝移植均有一定的局限性.因此,寻找更安全有效的治疗方法已成为当下研究的热点.间充质干细胞及其外泌体可通过减轻肝脏炎症反应,促进肝细胞增殖及再生、抗肝细胞凋亡,改善氧化应激和免疫调节等机制减轻肝损伤.本文就间充质干细胞及其外泌体在药物性肝损伤治疗中的作用进行简要综述,以期为进一步研究提供参考.
Role of mesenchymal stem cells and their exosomes in the treatment of drug-induced liver injury
The incidence rate of drug-induced liver injury(DILI)is increasing year by year with unknown mechanisms,and the treatment methods for DILI mainly include drugs,liver support systems,and liver transplantation,all of which have certain limitations.Therefore,the search for safer and more effective treatment methods has become a research hotspot at present.Studies have shown that mesenchymal stem cells and their exosomes can alleviate liver injury by reducing liver inflammation,promoting hepatocyte proliferation and regeneration,inhibiting the apoptosis of hepatocytes,improving oxidative stress,and regulating immunity.This article briefly reviews the role of mesenchymal stem cells and their exosomes in the treatment of DILI,so as to provide a reference for further research.

Mesenchymal Stem CellsExosomesDrug Induced Liver Injury

邢国静、罗龙龙、王丽菲、王顺娜、郑晓凤、卢利霞、张久聪

展开 >

中国人民解放军联勤保障部队第九四〇医院消化内科,兰州 730050

宁夏医科大学总医院消化内科,银川 750001

兰州大学第二医院消化内科,兰州 730030

间质干细胞 外泌体 药物性肝损伤

甘肃省卫生健康行业科研项目第九四〇医院研究生导师专项课题第九四〇医院青年培育项目中央高校优秀青年团队培育项目甘肃省非感染性肝病临床医学研究中心

GSWSKY2023-342023YXKY0202021yxky0543192022006521JR7RA017

2024

临床肝胆病杂志
吉林大学

临床肝胆病杂志

CSTPCD北大核心
影响因子:1.428
ISSN:1001-5256
年,卷(期):2024.40(3)
  • 46